Delivery Order SPE2DB20D1100-SPE2DB25FE1J6
- Not listed
- The Defense Logistics Agency awarded a $5,344.02 delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Norditropin Flexpro 15 mg/1.5 mL medication. This contract represents a child delivery order under a firm fixed-price arrangement with no set-aside designation, reflecting a competitively awarded procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 13,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Norditropin FlexPro 15 mg/1.5 mL pharmaceutical product, valued at $8,738.61. This non-set-aside competitive award is structured as a firm fixed-price delivery order with an ultimate completion date of August 19, 2025. The product will be delivered to the company's facility in Conshohocken, Pennsylvania. This delivery order represents a discrete transaction under...
- The Defense Logistics Agency awarded a delivery order valued at $1,746.15 to AmerisourceBergen Drug Corp for Norditropin FlexPro 15 mg/1.5 ml pharmaceutical product on July 28, 2025, with an ultimate completion date of July 29, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
- The Defense Logistics Agency awarded a $2,449.95 delivery order to AmerisourceBergen Drug Corp for Norditropin FlexPro 15 mg/1.5 mL pharmaceutical supplies, with an ultimate completion date of August 19, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is classified as a delivery order under the company's larger pharmaceutical supply arrangement. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a $4,190.76 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Norditropin FlexPro 15 mg/1.5 mL pharmaceutical product, with an ultimate completion date of August 8, 2025. This delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a child delivery order under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $1,502.30 delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Norditropin FlexPro 5 mg/1.5 mL medication. This firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order is scheduled for completion by August 11, 2025, with performance...
- The Defense Logistics Agency awarded a delivery order valued at $2,095.38 to AmerisourceBergen Drug Corp for Norditropin FlexPro 15 mg/1.5 mL on August 15, 2025, with completion scheduled for August 18, 2025. The contract employs firm fixed pricing and was awarded without set-aside designation through competitive procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a single...
- The Defense Logistics Agency awarded a $5,640.36 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for Norditropin FlexPro 15 mg/1.5 mL pharmaceutical product, with an ultimate completion date of July 28, 2025. This is a firm fixed-price, non-set-aside contract with performance in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which is valued at...
- The Defense Logistics Agency has awarded a delivery order valued at $2,432.40 to AmerisourceBergen Drug Corp for Norditropin FlexPro 10 mg/1.5 mL pharmaceutical product. This firm fixed price delivery order, issued on August 13, 2025, with an ultimate completion date of August 14, 2025, represents a child contract action under the company's larger indefinite delivery contract with DLA Troop Support Medical. The award was competitively awarded with no set-aside designation, and performance will...
- The Defense Logistics Agency awarded a $4,198.91 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Norditropin FlexPro 10 mg/1.5 mL medication, with performance to be completed by July 29, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's larger...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FE1J6Delivery Order
The Defense Logistics Agency awarded a $4,021.77 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Norditropin FlexPro 15 mg/1.5 mL pharmaceutical product. The contract, which is a child order under a larger indefinite delivery contract vehicle, has an ultimate completion date of August 19, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this competitive award. This delivery order falls under AmerisourceBergen's comprehensive $999,999,999.00 Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX) through December 2026, which authorizes the company to supply a broad range of pharmaceutical products and medical commodities to support military healthcare programs globally. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen routinely fulfills DLA pharmaceutical supply needs across multiple therapeutic domains, supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The current delivery order represents a routine fulfillment of the company's capability to provide specialty medications and pharmaceutical products on demand through the DLA's medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.0k | 8/18/25 |